Vaccination Outcomes in ESRD
Reports from the general population indicate improved hospitalization and/or mortality outcomes associated with influenza +/- pneumococcal vaccination. Annual flu vaccine is recommended but pneumococcal vaccine booster is only recommended at 5 years, without regard for waning titers. Because pulmonary infection is a major source of morbidity and mortality in ESRD, it may be worthwhile to do a cluster-randomized clinical ...more »
Reports from the general population indicate improved hospitalization and/or mortality outcomes associated with influenza +/- pneumococcal vaccination. Annual flu vaccine is recommended but pneumococcal vaccine booster is only recommended at 5 years, without regard for waning titers. Because pulmonary infection is a major source of morbidity and mortality in ESRD, it may be worthwhile to do a cluster-randomized clinical trial comparing outcomes from patients who receive re-vaccination for pneumococcus based on protective titers vs. standard practice - with all patients in each arm receiving flu vaccine annually.
« less full details »

